
GC73796
CVN293
Also known as 4-[7-fluoro-1-(pyridazin-3-ylmethyl)benzimidazol-2-yl]-1,2,5-oxadiazol-3-amine
CVN293 is a selective and brain permeable potassium ion (K+) channel KCNK13 inhibtor with IC50s of 41 nM and 28 nM for hKCNK13 and mKCNK13, respectively
ChemicalCAS2815296-08-1MW311.27FormulaC14H10FN7O
- CAS number
- 2815296-08-1
- Molecular weight
- 311.27
- Formula
- C14H10FN7O
- Solubility
- DMSO : 5 mg/mL (16·06 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- ONRXHVJHFORDDI-UHFFFAOYSA-N
- Catalogue number
- GC73796
- Brand
- GLPBIO
Computed properties PubChem CID 164861551 · XLogP 0.3 · TPSA 109 Ų · H-bond donors 1
- XLogP
- 0.3
- TPSA
- 109 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 23
SMILES C1=CC2=C(C(=C1)F)N(C(=N2)C3=NON=C3N)CC4=NN=CC=C4
Computed descriptors from PubChem (CID 164861551), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il